GPX4 and neoplasm: Following conditioning with a sublethal irradiation dose, MC38 tumor-bearing CD90.1+ mice received tumor-reactive polyclonal CD90.2+ WT or GPX4–/– CD8+ T cells followed by treatment further with or without α4-1BB.